Impact of Busulfan Exposure on Transplant Outcomes for Patients with Relapsed Multiple Myeloma Undergoing CD34-Selected Allogeneic Hematopoietic Stem Cell Transplant

被引：0
|
作者：
Lin, Andrew [1 ]
Drill, Esther [2 ]
Proli, Anthony J. [1 ]
Beyer, Kristen [1 ]
Bhatt, Valkal [1 ]
Devlin, Sean M. [2 ]
Koehne, Guenther [3 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, Dept Pharm, 1275 York Ave, New York, NY 10021 USA
[2] Mem Sloan Kettering Canc Ctr, Dept Biostat & Epidemiol, 1275 York Ave, New York, NY 10021 USA
[3] Mem Sloan Kettering Canc Ctr, Adult Bone Marrow Transplant Serv, Dept Med, 1275 York Ave, New York, NY 10021 USA
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2017年 / 23卷 / 03期
关键词：
D O I：
10.1016/j.bbmt.2016.12.200
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
395
引用
收藏
页码：S288 / S289
页数：2
相关论文
共 50 条
  • [31] CLINICAL OUTCOMES OF ADOLESCENT PATIENTS UNDERGOING HEMATOPOIETIC STEM CELL TRANSPLANT
    Midura, B.
    Lehmann, L.
    Duncan, C.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2008, 14 (02) : 27 - 27
  • [32] Outcomes of Rituximab for EBV Viremia/Post-Transplant Lymphoproliferative Disease in CD34+Selected Allogeneic Hematopoietic Stem Cell Transplantation
    Poppiti, Kristen
    Lin, Andrew
    Adel, Nelly G.
    Hilden, Patrick
    Castro-Malaspina, Hugo
    BLOOD, 2016, 128 (22)
  • [33] Outcome following CD34 selected allogeneic stem cell transplantation for patients with multiple myeloma
    Guillaume, H
    Moreau, P
    Delaunay, J
    Vigouroux, S
    Chevallier, P
    Mahé, B
    Le Gouill, S
    Dubruille, V
    Morineau, N
    Gastine, T
    Bercegay, S
    Saiag, S
    Saulquin, B
    Harousseau, JL
    Milpied, N
    BONE MARROW TRANSPLANTATION, 2006, 37 : S141 - S142
  • [34] CYTOMEGALOVIRUS PROPHYLAXIS WITH LETERMOVIR IN PATIENTS UNDERGOING ALLOGENEIC STEM CELL TRANSPLANT USING EX VIVO CD34+SELECTED GRAFTS
    Alonso-Martinez, Carla
    Gracia-Moya, Ariadna
    Perez-Gonzalez, Ana
    Molero, Antonieta
    Sanchez, Angela
    Albasanz-Puig, Adaia
    Ruiz-Camps, Isabel
    Farriols-Danes, Anna
    Valdivia-Vadell, Carolina
    Rivera-Sanchez, Lucas
    Guerra-Gonzalez, Maria
    Marrero, Patricia
    Garrido, Sara
    Sola, Maria
    Sanchez-Sancho, Pablo
    Barba, Pere
    Salamero, Olga
    Gorgas-Torner, MariaQueralt
    Orti, Guillermo
    Fox, Laura
    Bosch, Francesc
    Carreras-Soler, MariaJosep
    Valcarcel, David
    BONE MARROW TRANSPLANTATION, 2023, 58 (SUPP1) : 429 - 430
  • [35] Outcomes of Allogeneic Stem Cell Transplant in Patients with Relapsed/Refractory Hodgkin Lymphoma
    Ge, Shiliang
    Lepic, Kylie
    Bhindi, Ravi
    Berg, Tobias
    Khalaf, Dina
    Leber, Brian
    Radford, Michael
    Walker, Irwin
    Davies, Gwynivere
    Garcia-Horton, Alejandro
    CURRENT ONCOLOGY, 2025, 32 (02)
  • [36] ALLOGENEIC TRANSPLANT OF HEMATOPOIETIC PROGENITORS IN PATIENTS WITH MULTIPLE MYELOMA (MM)
    Garcia Torres, E.
    Alvarez Rivas, M. A.
    Rojas Contreras, R.
    Casano Sanchez, F. J.
    Martinez, F.
    Martin Calvo, C.
    HAEMATOLOGICA, 2015, 100 : 54 - 55
  • [37] Characteristics, Time Trend and Outcomes of Patients Undergoing Autologous Stem Cell Transplant for Multiple Myeloma
    Ailawadhi, Sikander
    Patel, Raj
    Meghji, Zahara
    Cochuyt, Jordan
    Hodge, David
    Vivek, Roy
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (03) : S138 - S139
  • [38] IMPACT OF METFORMIN USE IN THE OUTCOMES OF MULTIPLE MYELOMA PATIENTS POST STEM CELL TRANSPLANT
    Duma, N.
    Vera-Aguilera, J.
    Paludo, J.
    Wang, Y.
    Anagnostou, T.
    Fonder, A.
    Buadi, F.
    Kumar, S.
    Lacy, M.
    Hayman, S.
    Dispenzieri, A.
    Gertz, M.
    Dingli, D.
    HAEMATOLOGICA, 2017, 102 : 508 - 508
  • [39] The Impact of CD34+Cell Collection Yields for Autologous Transplant on Survival Outcomes in Multiple Myeloma
    Lebel, Eyal
    Lajkosz, Katherine
    Masih-Khan, Esther
    Reece, Donna
    Trudel, Suzanne
    Tiedemann, Rodger
    Prica, Anca
    Kukreti, Vishal
    Chen, Christine
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 (11): : 850 - 856
  • [40] Autologous CD34-selected blood progenitor cell transplants for patients with advanced multiple myeloma
    G Schiller
    R Vescio
    C Freytes
    G Spitzer
    M Lee
    CH Wu
    J Cao
    JC Lee
    A Lichtenstein
    M Lill
    R Berenson
    J Berenson
    Bone Marrow Transplantation, 1998, 21 : 141 - 145
12345